Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo
| Autor: | De Vera, Albert A., Gupta, Pranav, Lei, Zining, Liao, Dan, Narayanan, Silpa, Teng, Qiuxu, Reznik, Sandra E., Chen, Zhe-Sheng |
|---|---|
| Zdroj: | In Cancer Letters 1 February 2019 442:91-103 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect